about
Nanotechnology-based inhalation treatments for lung cancer: state of the artSmall Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and DevelopmentDietary Phytochemicals: Natural Swords Combating Inflammation and Oxidation-Mediated Degenerative DiseasesEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Role of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseAlzheimer's disease and type 2 diabetes via chronic inflammatory mechanismsProtein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitusPrediction of structure of human WNT-CRD (FZD) complex for computational drug repurposingSynthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholNeuronal cellular responses to extremely low frequency electromagnetic field exposure: implications regarding oxidative stress and neurodegenerationAntibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatmentTetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysisAn overview on the correlation of neurological disorders with cardiovascular disease.Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients.Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitalsAssessment of the role of general, biochemical and family history characteristics in kidney stone formationExperimental model for ELF-EMF exposure: Concern for human health.The association of nutritional profile and prognosis of degenerative diseases associated with carbohydrate and lipid metabolism at high altitude of district Ziarat, PakistanClinical biomarkers in sickle cell disease.A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update.Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.The role of epigenetics in personalized medicine: challenges and opportunities.Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysisObservations on the expression of human papillomavirus major capsid protein in HeLa cells.Interaction of Glucagon G-Protein Coupled Receptor with Known Natural Antidiabetic Compounds: Multiscoring In Silico Approach.Phage Display Technique: A Novel Medicinal Approach To Overcome Antibiotic Resistance By Using Peptide-Based Inhibitors Against Β-Lactamases.Nanotechnology-based approaches in anticancer researchDevelopment of interspecific Solanum lycopersicum and screening for Tospovirus resistance.Evaluation of propolis, honey, and royal jelly in amelioration of peripheral blood leukocytes and lung inflammation in mouse conalbumin-induced asthma model.In silico Analysis of AMP-Activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats.Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase.Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.Evaluation of Anti-Inflammatory Properties of Isoorientin Isolated from Tubers of Pueraria tuberosaEffects of Honey on Oral Mucositis among Pediatric Cancer Patients Undergoing Chemo/Radiotherapy Treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia.Hepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy.A Bayesian Model for the Prediction and Early Diagnosis of Alzheimer's Disease.An overview on potential neuroprotective compounds for management of Alzheimer's disease.Cancer chemoprevention by polyphenols and their potential application as nanomedicine.Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion
P50
Q26774177-EA8CC12E-53DE-46A3-B163-5C883C312A22Q26776241-DDD85EC5-C37E-41EC-86F0-5B9189E13BB4Q28067382-116F9F03-01BB-4638-844A-BE0FCA04BD41Q28073956-DB11747D-8B2D-4E5F-9C3B-621E73F1B4CAQ28083039-8671AF21-E4A9-4116-8A1A-3DFA2EE2AB09Q28086892-58C700D7-ECB0-4C6F-B5DC-8751893AB5D4Q28397425-DA13B978-E557-480E-A2EA-247A6B44BE49Q28485313-FA3B5394-3281-4F56-86C3-BED6B24024CCQ28818062-4FC135B1-A69F-493C-8E08-3A014FFE4857Q34050769-B2B65C51-504D-4E09-9D06-19823B8D0456Q34456773-7BAC70B6-DA74-485A-A1CA-EC30E7F2BD6AQ34743671-74DED5C5-8E51-4D24-BB11-846AE49F356BQ34800195-57EFF4B9-CE6F-44A5-815B-01F2B8BC7D47Q34800266-6B1862D0-363D-41AA-B96A-2E2AE45E88E5Q34800300-0778C709-57FF-4867-8694-F531C99231C2Q34800324-2F8B33A6-63BC-4102-BC15-85DB2B03FA2BQ34800342-9C98ADE4-7329-41ED-8D0C-B3392BFA43D3Q34800442-195AC20A-E9B4-4811-B403-5D24962EA549Q34800466-24F9F658-6F0C-440A-A104-399CF6BE2D88Q34995334-1DEFA381-24CC-4793-97DB-2EC78544DFCDQ34995338-DBCD06FB-BDFB-4A04-A80B-D44582EC568DQ35043066-AF7D63CB-7CF2-49D9-A67C-7BA304F86E61Q35286102-0774DC93-D147-4533-BB29-209A75241929Q35660694-27290604-AA9D-45A9-A7B7-B85731073CB0Q35868453-070EEEA4-3ECF-45DB-87BD-F231BBD15DE6Q36088067-9DD6ADE9-9297-4308-A75F-62C8DF1A5E77Q36168983-CEC78C7E-58AD-439D-A773-E695926A44FBQ36221610-B64116F1-CD9F-4898-B7CB-9013A7E2C38DQ36222588-1DA17628-C042-4E10-A8D7-942F5FE93C40Q36308169-CCB11168-5E9C-4DBD-977A-95B0C47BC522Q36657068-CDE6748D-B46B-44DE-A1AB-B7A70CA39BC7Q36727886-0ABA636D-C75D-45AB-96CC-B691DFB8D179Q36727908-6EDEA6FA-912F-462B-ABB7-D174C6A11F70Q37627950-4FBCE5B8-1476-4B01-99B1-742F5F60D144Q37657218-0A394AD4-32C5-4EA1-8CE7-F928F4806DE4Q37699893-6ED01004-8A56-42A9-A4F7-C68FD329B5ADQ37731885-97D6900A-1C73-425D-9AAE-E8C1A5AE3531Q38067791-5129E6AE-4715-4F2A-A749-030DA6334C08Q38093653-D82F5E92-22FB-4065-85F8-03866DE7DAD0Q38108308-ED48E1D3-0BAF-4BC4-8912-254B702C342A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mohammad Amjad Kamal
@ast
Mohammad Amjad Kamal
@en
Mohammad Amjad Kamal
@es
Mohammad Amjad Kamal
@sl
type
label
Mohammad Amjad Kamal
@ast
Mohammad Amjad Kamal
@en
Mohammad Amjad Kamal
@es
Mohammad Amjad Kamal
@sl
altLabel
Amjad Kamal
@en
MA Kamal
@en
prefLabel
Mohammad Amjad Kamal
@ast
Mohammad Amjad Kamal
@en
Mohammad Amjad Kamal
@es
Mohammad Amjad Kamal
@sl
P1053
J-2918-2014
P106
P1153
56340070000
P2038
Mohammad_KAMAL
P21
P2798
P31
P3829
P496
0000-0003-0088-0565